A clinical dose of angiotensin-converting enzyme (ACE) inhibitor and heterozygous ACE deletion exacerbate Alzheimer's disease pathology in mice

Inhibition of angiotensin-converting enzyme (ACE) is a strategy used worldwide for managing hypertension. In addition to converting angiotensin I to angiotensin II, ACE also converts neurotoxic β-amyloid protein 42 (Aβ42) to Aβ40. Because of its neurotoxicity, Aβ42 is believed to play a causative ro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Biol Chem
Main Authors: Liu, Shuyu, Ando, Fujiko, Fujita, Yu, Liu, Junjun, Maeda, Tomoji, Shen, Xuefeng, Kikuchi, Kota, Matsumoto, Aoi, Yokomori, Mirai, Tanabe-Fujimura, Chiaki, Shimokata, Hiroshi, Michikawa, Makoto, Komano, Hiroto, Zou, Kun
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Biochemistry and Molecular Biology 2019
Assuntos:
Molecular Bases of Disease
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6597817/
https://ncbi.nlm.nih.gov/pubmed/31072831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.RA118.006420
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados